Brief: Acticor Biotech Announce First Patient In Liberate Clinical Trial With University Of Birmingham

Acticor Biotech SA

07/02/2024 17:07

Feb 7 (Reuters) - Acticor Biotech SA  ALACT.PA :
    * UNIVERSITY OF BIRMINGHAM AND ACTICOR BIOTECH ANNOUNCE
FIRST
PATIENT IN LIBERATE CLINICAL TRIAL
    * THE QUEEN ELIZABETH HOSPITAL IN BIRMINGHAM HAS BEEN READY
FOR
RECRUITMENT SINCE 24 JANUARY 2024. THE NORTHERN GENERAL HOSPITAL
IN SHEFFIELD IS EXPECTED TO BE ACTIVE BY THE END OF FEBRUARY
2024
    * THE AIM OF THE STUDY IS TO ASSESS THE SAFETY AND EFFICACY
OF
GLENZOCIMAB 1000 MG COMPARED WITH PLACEBO IN REDUCING THE SIZE
OF MYOCARDIAL INFARCTION AFTER 90 DAYS

Source text for Eikon:  ID:nBw7PMXxPa 
Further company coverage:  ALACT.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))